Hawkins, Inc. Reports Third Quarter Fiscal 2025 Results

Rhea-AI Summary

Hawkins Inc (NASDAQ: HWKN) reported strong Q3 FY2025 results with record performance in key metrics. Revenue grew 8% to $226.2M, driven by a 22% increase in Water Treatment segment revenue to $99.8M. The company achieved net income of $15.0M and diluted EPS of $0.72.

The Water Treatment segment showed robust growth from acquisitions and 9% organic volume growth. The Industrial segment saw a slight revenue decline of 1% due to lower selling prices, while Health and Nutrition segment revenue increased 3%. Gross profit rose 15% to $48.4M, with notable improvements in Water Treatment (29%) and Health and Nutrition (31%) segments.

The company maintains a strong balance sheet with a leverage ratio of 0.7x trailing 12-month proforma adjusted EBITDA. Adjusted EBITDA increased 13% to $33.6M. Management expects continued growth in Water Treatment and Health and Nutrition segments.

Positive

• Record Q3 results across revenue, gross profit, operating income, and adjusted EBITDA
• Water Treatment segment revenue grew 22% with 9% organic volume growth
• Overall gross profit increased 15% to $48.4M
• 27th consecutive quarter of year-over-year operating income growth
• Strong balance sheet with low leverage ratio of 0.7x
• Adjusted EBITDA increased 13% to $33.6M

Negative

• Industrial segment revenue declined 1% year-over-year
• Selling, general and administrative expenses increased 15% to $27.4M
• Higher effective tax rate of 26% compared to 18% in prior year

Insights

Financial Analyst

Hawkins delivered another quarter of record performance, highlighted by robust growth in its Water Treatment segment. The 22% revenue surge in Water Treatment to $99.8 million reflects successful execution of the company's acquisition strategy, with seven deals completed in 18 months, plus impressive 9% organic growth.

The company's profitability metrics show strong operational execution. Gross margin expanded to 21% from 20%, while adjusted EBITDA grew 13% to $33.6 million. The trailing 12-month adjusted EBITDA of $162 million demonstrates sustained earnings power.

Segment performance reveals divergent trends:

• Water Treatment achieved 29% gross profit growth with margin expansion to 26%
• Industrial faced expected headwinds from lower commodity costs, though volumes increased
• Health & Nutrition showed encouraging momentum with 31% gross profit growth and margin improvement to 21%

The balance sheet remains strong with a conservative leverage ratio of 0.7x, providing flexibility for continued strategic acquisitions. The recent Water Guard acquisition marks strategic entry into North Carolina, expanding the company's geographic footprint to 28 states.

ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025.

Third Quarter Fiscal Year 2025 Highlights:

• Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.
• Overall revenue growth of 8%, once again driven by the Water Treatment segment growth of 22% over the same period of the prior year.
• Gross profit growth of 15% over the same period of the prior year, with double-digit percentage growth for both the Water Treatment and Health and Nutrition segments.
• Third quarter operating income of $21.1 million, our 27th consecutive quarter of year-over-year operating income growth.
• Income before income taxes grew 12% over the same period of the prior year.
• Diluted earnings per share (“EPS”) of $0.72 compared to $0.71 in the prior year.
• Adjusted EBITDA, a non-GAAP measure, of $33.6 million, a 13% increase over the same period of the prior year. Trailing 12-month adjusted EBITDA was $162 million.
• Year to date, revenue was up 5% over the prior year and EPS was up 11%.
  
  

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“For each of the last four quarters, we have achieved record year-over-year performance for several of our key metrics. In the third quarter, our record performance was once again driven by the Water Treatment business, as we realized the benefits of the seven acquisitions we have completed over the last 18 months. Within the quarter we saw strong revenue growth of 22% in our Water Treatment business, with this growth driven by both revenue from our recent acquisitions as well as strong organic volume growth of 9%. Revenue in our Industrial segment declined year over year, as expected, due primarily to reduced selling prices driven by lower commodity costs and product mix, offset slightly by overall volumes being up. Health and Nutrition revenues increased due to growth of our manufactured product sales. Overall, we saw 8% revenue growth with gross profit increasing 15%, operating income increasing 14% and pretax income increasing 12%.”

Mr. Hawkins continued, “Our balance sheet continues to be strong. In the quarter, our net borrowings of $10 million helped fund our acquisition of Water Guard, our first water treatment site in North Carolina. Our leverage ratio was 0.7x trailing 12-month proforma adjusted EBITDA at the end of the quarter. As we close out our fiscal year, we expect continued growth within the Water Treatment and Health and Nutrition segments. We expect to see our Industrial segment continue to perform similar to the first nine months of fiscal 2025.”

Third Quarter Financial Highlights:

NET INCOME

For the third quarter of fiscal 2025, the Company reported net income of $15.0 million, or $0.72 per diluted share, compared to net income for the third quarter of fiscal 2024 of $14.9 million, or $0.71 per diluted share. The prior year EPS was positively impacted by $0.08 per share due to an unusual favorable tax adjustment.

REVENUE

Sales were $226.2 million for the third quarter of fiscal 2025, an increase of $17.7 million, or 8%, from sales of $208.5 million in the same period a year ago. Water Treatment segment sales increased $17.8 million, or 22%, to $99.8 million for the current quarter, from $82.0 million in the same period a year ago. Water Treatment sales increased as a result of added sales from our acquired businesses as well as increased sales volumes in our legacy business. Despite showing sequential improvement, Industrial segment sales decreased $1.0 million, or 1%, to $92.0 million for the current quarter, from $93.0 million in the same period a year ago. Sales decreased as a result of lower selling prices on certain products, driven by lower raw material costs and product mix changes. Health and Nutrition segment sales increased $1.0 million, or 3%, to $34.5 million for the current quarter, from $33.5 million in the same period a year ago. Health and Nutrition sales increased due to increased sales of our manufactured products.

GROSS PROFIT

Gross profit increased $6.2 million, or 15%, to $48.4 million, or 21% of sales, for the current quarter, from $42.2 million, or 20% of sales, in the same period a year ago. During the current quarter, the LIFO reserve decreased, and gross profit increased, by $0.8 million, primarily due to lower anticipated year-end prices on certain products. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $2.5 million.

Gross profit for the Water Treatment segment increased $5.8 million, or 29%, to $26.0 million, or 26% of sales, for the current quarter, from $20.2 million, or 25% of sales, in the same period a year ago. During the current quarter, the LIFO reserve decreased, and gross profit increased, by $0.1 million. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $0.4 million. Water Treatment segment gross profit increased as a result of increased sales, including the incremental sales from our acquired businesses.

Gross profit for the Industrial segment decreased $1.3 million, or 8%, to $15.2 million, or 17% of sales, for the current quarter, from $16.5 million, or 18% of sales, in the same period a year ago. During the current quarter, the LIFO reserve decreased, and gross profit increased, by $0.6 million. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $2.1 million. Industrial segment gross profit decreased primarily as a result of product mix changes and the change in the LIFO reserve.

Gross profit for our Health and Nutrition segment increased $1.7 million, or 31%, to $7.2 million, or 21% of sales, for the current quarter, from $5.5 million, or 16% of sales, in the same period a year ago. Health and Nutrition segment gross profit increased as a result of the increased sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses increased $3.6 million, or 15%, to $27.4 million, or 12% of sales, for the current quarter, from $23.8 million, or 11% of sales, in the same period a year ago. Expenses increased primarily due to $1.9 million in added costs from the acquired businesses in our Water Treatment segment, including amortization of intangibles of $0.8 million, as well as other increased variable costs.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended December 29, 2024 was $33.6 million, an increase of $3.9 million, or 13%, from $29.7 million in the same period a year ago.

INCOME TAXES

Our effective income tax rate was 26% for the current quarter and 18% for the same period a year ago. The effective tax rate in the third quarter of both years was impacted by favorable tax provision adjustments recorded, with the prior year being unusually beneficial and the current year being more in line with expectations. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

BALANCE SHEET

At the end of the third quarter, our working capital was $27 million higher than the end of fiscal 2024 due primarily to seasonally lower liabilities as well as increased inventories. During the quarter, we paid down $10 million on our line of credit. Our total debt outstanding at the end of the third quarter was $114.0 million and our leverage ratio was 0.70x our trailing 12-month proforma adjusted EBITDA, as compared to 0.66x of trailing twelve-month adjusted EBITDA at the end of fiscal 2024.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 61 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $919 million of revenue in fiscal 2024 and has approximately 1,000 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

Adjusted EBITDA	Three Months Ended								Nine months ended								Trailing 12-months ended
(In thousands)	December 29, 2024				December 31, 2023				December 29, 2024				December 31, 2023				December 29, 2024
Net Income (GAAP)	$	15,021			$	14,885			$	68,018			$	61,531			$	81,851
Interest expense, net		1,216				1,168				3,906				3,033				5,155
Income tax expense		5,262				3,274				23,943				20,289				29,435
Amortization of intangibles		3,213				2,392				9,211				5,786				11,963
Depreciation expense		6,899				5,951				20,157				17,063				26,358
Non-cash compensation expense		1,723				1,287				5,022				3,506				6,396
Non-recurring acquisition expenses		298				710				580				832				664
Adjusted EBITDA	$	33,632			$	29,667			$	130,837			$	112,040			$	161,822

HAWKINS, INC. CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (In thousands, except share and per-share data)
	Three Months Ended								Nine Months Ended
	December 29, 2024				December 31, 2023				December 29, 2024				December 31, 2023
Sales	$	226,205			$	208,496			$	729,113			$	696,142
Cost of sales		(177,781	)			(166,248	)			(555,812	)			(548,017	)
Gross profit		48,424				42,248				173,301				148,125
Selling, general and administrative expenses		(27,361	)			(23,774	)			(78,702	)			(64,173	)
Operating income		21,063				18,474				94,599				83,952
Interest expense, net		(1,216	)			(1,168	)			(3,906	)			(3,033	)
Other income		436				853				1,268				901
Income before income taxes		20,283				18,159				91,961				81,820
Income tax expense		(5,262	)			(3,274	)			(23,943	)			(20,289	)
Net income	$	15,021			$	14,885			$	68,018			$	61,531
Weighted average number of shares outstanding - basic		20,766,764				20,781,632				20,780,213				20,864,349
Weighted average number of shares outstanding - diluted		20,875,387				20,907,321				20,902,456				21,004,077
Basic earnings per share	$	0.72			$	0.72			$	3.27			$	2.95
Diluted earnings per share	$	0.72			$	0.71			$	3.25			$	2.93
Cash dividends declared per common share	$	0.18			$	0.16			$	0.52			$	0.47

HAWKINS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share data)
	December 29, 2024				March 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	8,305			$	7,153
Trade accounts receivables, net		111,521				114,477
Inventories		81,634				74,600
Prepaid expenses and other current assets		8,895				6,596
Total current assets		210,355				202,826
PROPERTY, PLANT, AND EQUIPMENT:		410,427				386,648
Less accumulated depreciation		189,984				177,774
Net property, plant, and equipment		220,443				208,874
OTHER ASSETS:
Right-of-use assets		13,096				11,713
Goodwill		116,738				103,399
Intangible assets, net of accumulated amortization		130,474				116,626
Deferred compensation plan asset		11,892				9,584
Other		4,242				4,912
Total other assets		276,442				246,234
Total assets	$	707,240			$	657,934
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable — trade	$	39,891			$	56,387
Accrued payroll and employee benefits		18,371				19,532
Income tax payable		—				1,943
Current portion of long-term debt		9,913				9,913
Environmental remediation		7,700				7,700
Other current liabilities		8,379				7,832
Total current liabilities		84,254				103,307
LONG-TERM LIABILITIES:
Long-term debt, less current portion		103,884				88,818
Long-term lease liability		10,613				9,530
Pension withdrawal liability		3,252				3,538
Deferred income taxes		22,120				22,406
Deferred compensation liability		13,413				11,764
Earnout liability		12,262				11,235
Other long-term liabilities		461				1,310
Total long-term liabilities		166,005				148,601
Total liabilities		250,259				251,908
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,766,764 and 20,790,261 shares issued and outstanding as of December 29, 2024 and March 31, 2024, respectively		208				208
Additional paid-in capital		32,783				38,154
Retained earnings		421,682				364,549
Accumulated other comprehensive income		2,308				3,115
Total shareholders’ equity		456,981				406,026
Total liabilities and shareholders’ equity	$	707,240			$	657,934

HAWKINS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands)
	Nine Months Ended
	December 29, 2024				December 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	68,018			$	61,531
Reconciliation to cash flows:
Depreciation and amortization		29,368				22,849
Change in fair value of earnout liability		1,027				—
Operating leases		2,557				1,884
Gain on deferred compensation assets		(1,268	)			(901	)
Stock compensation expense		5,022				3,506
Other		(4	)			70
Changes in operating accounts providing (using) cash:
Trade receivables		6,157				22,500
Inventories		(5,682	)			25,665
Accounts payable		(16,026	)			(14,334	)
Accrued liabilities		(1,698	)			(610	)
Lease liabilities		(2,565	)			(1,804	)
Income taxes		(2,636	)			(1,824	)
Other		(2,018	)			(922	)
Net cash provided by operating activities		80,252				117,610
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment		(30,008	)			(28,248	)
Acquisitions		(43,400	)			(78,855	)
Other		586				723
Net cash used in investing activities		(72,822	)			(106,380	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid		(10,885	)			(9,886	)
New shares issued		1,297				2,243
Payroll taxes paid in exchange for shares withheld		(2,541	)			(2,140	)
Shares repurchased		(9,149	)			(11,272	)
Payments on revolving loan		(50,000	)			(67,000	)
Proceeds from revolving loan borrowings		65,000				75,000
Net cash used in financing activities		(6,278	)			(13,055	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		1,152				(1,825	)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		7,153				7,566
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	8,305			$	5,741
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for income taxes	$	26,566			$	22,125
Cash paid for interest	$	4,208			$	3,252
Noncash investing activities - capital expenditures in accounts payable	$	1,152			$	2,887

HAWKINS, INC. REPORTABLE SEGMENTS (UNAUDITED) (In thousands)
	Water Treatment				Industrial				Health and Nutrition				Total
Three months ended December 29, 2024:
Sales	$	99,752			$	91,997			$	34,456			$	226,205
Gross profit		26,027				15,180				7,217				48,424
Selling, general, and administrative expenses		16,054				7,058				4,249				27,361
Operating income		9,973				8,122				2,968				21,063
Three months ended December 31, 2023:
Sales	$	82,019			$	92,990			$	33,487			$	208,496
Gross profit		20,241				16,495				5,512				42,248
Selling, general, and administrative expenses		12,470				7,292				4,012				23,774
Operating income		7,771				9,203				1,500				18,474
Nine months ended December 29, 2024:
Sales	$	341,456			$	285,135			$	102,522			$	729,113
Gross profit		96,572				55,324				21,405				173,301
Selling, general and administrative expenses		45,732				20,649				12,321				78,702
Operating income		50,840				34,675				9,084				94,599
Nine months ended December 31, 2023:
Sales	$	276,595			$	312,398			$	107,149			$	696,142
Gross profit		75,957				53,645				18,523				148,125
Selling, general and administrative expenses		31,741				20,673				11,759				64,173
Operating income		44,216				32,972				6,764				83,952

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:	Jeffrey P. Oldenkamp
	Executive Vice President and Chief Financial Officer
	612/331-6910
	ir@HawkinsInc.com

FAQ

What was Hawkins (HWKN) revenue growth in Q3 2025?

Hawkins reported an 8% revenue growth to $226.2 million in Q3 FY2025 compared to $208.5 million in the same period last year.

How much did HWKN's Water Treatment segment grow in Q3 2025?

The Water Treatment segment grew 22% to $99.8 million, including both acquisition-driven growth and 9% organic volume growth.

What was Hawkins (HWKN) earnings per share in Q3 2025?

Hawkins reported diluted earnings per share of $0.72 in Q3 FY2025, compared to $0.71 in the same period last year.

What was HWKN's adjusted EBITDA for Q3 2025?

Adjusted EBITDA was $33.6 million in Q3 FY2025, representing a 13% increase from $29.7 million in the same period last year.

What is Hawkins (HWKN) current leverage ratio?

Hawkins reported a leverage ratio of 0.70x trailing 12-month proforma adjusted EBITDA at the end of Q3 FY2025.